Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.

Angelo Ghezzi,Brenda Banwell,Amit Bar-Or,Tanuja Chitnis,Russell C. Dale,Mark P. Gorman,Barbara Kornek,Lauren B. Krupp,Kristen M. Krysko,Margherita Nosadini,Kevin Rostasy,Jonatan Salzer,Teri Schreiner,Silvia Tenembaum,Emmanuelle Waubant

Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.

2020

Angelo Ghezzi
Brenda Banwell
Amit Bar-Or
Tanuja Chitnis
Russell C. Dale
Mark P. Gorman
Barbara Kornek
Lauren B. Krupp
Kristen M. Krysko
Margherita Nosadini
Kevin Rostasy
Jonatan Salzer
Teri Schreiner
Silvia Tenembaum
Emmanuelle Waubant

Anti-CD20 therapies have established efficacy in the treatment of immune-mediated neurological and non-neurological diseases. Rituximab, one of the first B-cell-directed therapies, is relatively in...

Keywords:

Rituximab
Medicine
Multiple sclerosis
Demyelinating Disorder
in patient
Pediatrics
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations